Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)
CUSIP: 75943R102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 4,389,099
- Total 13F shares
- 22,458,535
- Share change
- +132,843
- Total reported value
- $223,544,699
- Put/Call ratio
- 89%
- Price per share
- $9.95
- Number of holders
- 100
- Value change
- +$3,805,625
- Number of buys
- 48
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 75943R102:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
636%
|
27,904,963
|
$236,075,987 | — | 31 Dec 2025 | |
| Commodore Capital LP |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
17,000,000
|
$143,820,000 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
13,859,172
|
$117,248,595 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
13,228,502
|
$111,913,127 | — | 31 Dec 2025 | |
| Casdin Capital, LLC |
13D/G
13F
|
Company |
7.5%
|
13,003,574
|
$110,010,236 | $0 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
221%
|
9,691,445
|
$81,989,624 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
190%
|
8,345,364
|
$70,601,779 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
146%
|
6,426,111
|
$54,364,899 | — | 31 Dec 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
107%
|
4,701,506
|
$39,774,741 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
78%
|
3,409,363
|
$28,849,082 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
73%
|
3,220,186
|
$27,242,774 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
68%
|
2,984,125
|
$25,245,698 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
57%
|
2,480,350
|
$20,983,096 | — | 31 Dec 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
51%
|
2,232,451
|
$18,886,535 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
48%
|
2,099,912
|
$17,765,256 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
46%
|
2,018,464
|
$17,076,206 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
43%
|
1,903,245
|
$16,101,453 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
42%
|
1,859,634
|
$15,732,503 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
37%
|
1,645,403
|
$13,921,000 | — | 31 Dec 2025 | |
| Alphabet Inc. |
13F
|
Company |
36%
|
1,568,753
|
$13,271,651 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
36%
|
1,560,265
|
$13,199,842 | — | 31 Dec 2025 | |
| Sanjiv Patel |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,997,944
mixed-class rows
|
$12,672,981 | -$991,208 | 13 Jan 2026 | |
| Kynam Capital Management, LP |
13F
|
Company |
32%
|
1,424,259
|
$12,049,231 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
29%
|
1,289,800
|
$10,911,708 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
27%
|
1,163,124
|
$9,840,028 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
26%
|
1,160,117
|
$9,814,590 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
26%
|
1,141,880
|
$9,660,305 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
26%
|
1,138,688
|
$9,633,302 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
26%
|
1,136,702
|
$9,616,499 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
24%
|
1,040,949
|
$8,806,429 | — | 31 Dec 2025 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
23%
|
1,000,000
|
$8,460,000 | — | 31 Dec 2025 | |
| Kalehua Capital Management LLC |
13F
|
Company |
21%
|
901,457
|
$7,626,326 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
20%
|
896,909
|
$7,587,850 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
20%
|
865,481
|
$7,321,970 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
19%
|
837,417
|
$7,084,548 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
15%
|
679,115
|
$5,745,313 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
15%
|
647,899
|
$5,481,226 | — | 31 Dec 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
13%
|
560,298
|
$4,740,121 | — | 31 Dec 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
12%
|
545,079
|
$4,611,368 | — | 31 Dec 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
12%
|
541,124
|
$4,577,909 | — | 31 Dec 2025 | |
| Elmind Capital, LP |
13F
|
Company |
12%
|
536,946
|
$4,542,563 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
11%
|
500,000
|
$4,230,000 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
11%
|
489,137
|
$4,138,099 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
11%
|
472,045
|
$3,993,501 | — | 31 Dec 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
10%
|
460,000
|
$3,891,600 | — | 31 Dec 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
10%
|
457,869
|
$3,874,000 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
10%
|
456,648
|
$3,862,000 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
10%
|
451,500
|
$3,819,690 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
9.9%
|
432,493
|
$3,658,891 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
9.7%
|
425,958
|
$3,603,604 | — | 31 Dec 2025 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q1 2026
As of 31 Mar 2026,
Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,458,535 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD PORTFOLIO MANAGEMENT LLC, Alphabet Inc., VANGUARD FIDUCIARY TRUST CO, Connor, Clark & Lunn Investment Management Ltd., Invesco Ltd., CONGRESS ASSET MANAGEMENT CO, UBS Group AG, and BESSEMER GROUP INC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
224
Q1 2026 holders
100
Holder diff
-124
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.